| 000 | 01456 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513052856.0 | ||
| 264 | 0 | _c19941129 | |
| 008 | 199411s 0 0 eng d | ||
| 022 | _a0014-5793 | ||
| 024 | 7 |
_a10.1016/0014-5793(94)01056-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpencer, J P | |
| 245 | 0 | 0 |
_aIntense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease. _h[electronic resource] |
| 260 |
_bFEBS letters _cOct 1994 |
||
| 300 |
_a246-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBrain Chemistry |
| 650 | 0 | 4 | _aCatalysis |
| 650 | 0 | 4 |
_aCopper _xanalysis |
| 650 | 0 | 4 |
_aDNA _xdrug effects |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDopamine _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen Peroxide |
| 650 | 0 | 4 |
_aIron _xanalysis |
| 650 | 0 | 4 |
_aLevodopa _xpharmacology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aJenner, A | |
| 700 | 1 | _aAruoma, O I | |
| 700 | 1 | _aEvans, P J | |
| 700 | 1 | _aKaur, H | |
| 700 | 1 | _aDexter, D T | |
| 700 | 1 | _aJenner, P | |
| 700 | 1 | _aLees, A J | |
| 700 | 1 | _aMarsden, D C | |
| 700 | 1 | _aHalliwell, B | |
| 773 | 0 |
_tFEBS letters _gvol. 353 _gno. 3 _gp. 246-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-5793(94)01056-0 _zAvailable from publisher's website |
| 999 |
_c7957199 _d7957199 |
||